tirzepatide sydney 115 days until summer has us thinking it might be time to book that consult 👀, Tirzepatide is an FDA-approved, once-weekly injection for weight loss that works as both a GIP and GLP-1 Tirzepatide | Research Peptide Australia

Ozempic is approved mainly for type 2 diabetes, while Wegovy is approved for weight management

For cardiovascular applications, this monitoring becomes particularly important given the potential for blood pressure and heart rhythm effects

They also do not contain GLP-1 active ingredients like semaglutide

These may include but are not limited to: Constipation Diarrhea Nausea Vomiting In some cases, GLP-1 medications may cause serious reactions, such as pancreatitis or vision changes

Cng tm hiu nh

PRISMA 2020 Checklist Figure & Data References Citations Citations to this article as recorded by The efficacy and safety of dual GIP/GLP1 receptor agonists (tirzepatide) in diabetes and obesity: a systematic review and network meta-analysis Karolina Hoffmann, Micha Michalak, Manfredi Rizzo, Viviana Maggio, Anna Paczkowska Expert Opinion on Drug Safety.2026